UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 22, pp. 2109 - 2121
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - genetics | Prognosis | Prospective Studies | Carcinoma, Non-Small-Cell Lung - genetics | Lung Neoplasms - mortality | Humans | Risk Factors | Male | Phylogeny | Carcinoma, Non-Small-Cell Lung - mortality | Genetic Heterogeneity | DNA Copy Number Variations | Exome | Disease-Free Survival | Female | Neoplasm Recurrence, Local - genetics | Mutation | Chromosomal Instability | Sequence Analysis, DNA - methods | Evolution, Molecular | Lung cancer, Non-small cell | Chromosomes | Research | Medical research | Chromatin | Epidermal growth factor receptors | Transcription | p53 Protein | Lung cancer | DNA damage | Non-small cell lung carcinoma | Oncology | Genomes | Multivariate analysis | DNA repair | Survival | Cyclin-dependent kinase 4 | Genomic instability | Pathology | Census | Lungs | Evolution | Death | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
PharmacoEconomics, ISSN 1170-7690, 07/2017, Volume 35, Issue 7, pp. 717 - 726
Economics | Social Sciences | Life Sciences & Biomedicine | Health Care Sciences & Services | Pharmacology & Pharmacy | Business & Economics | Health Policy & Services | Science & Technology | Evidence-Based Practice | Cost-Benefit Analysis | Humans | Male | Neoplasms, Hormone-Dependent - drug therapy | Gonadotropin-Releasing Hormone - agonists | Prostatic Neoplasms - drug therapy | Oligopeptides - therapeutic use | Prostate cancer | Cancer patients | Care and treatment | Medical research | Antigens | Mortality | Committees | Metastasis | Medical screening | Quality of life | Studies | Mens health | Testosterone | Androgens | Surgery | Cost analysis | Urogenital system
Journal Article
Clinical radiology, ISSN 0009-9260, 2015, Volume 70, pp. S12 - S12
Journal Article
Cell (Cambridge), ISSN 0092-8674, 11/2017, Volume 171, Issue 6, pp. 1259 - 1271.e11
neoantigen | lung cancer | chromosomal instability | bioinformatics | cancer evolution | immune-editing | copy number | loss of heterozygosity | immune-escape | heterogeneity | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Tumor Escape | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Middle Aged | HLA Antigens - immunology | Lung Neoplasms - pathology | Male | Lung Neoplasms - therapy | HLA Antigens - genetics | Loss of Heterozygosity | Carcinoma, Non-Small-Cell Lung - immunology | Carcinoma, Non-Small-Cell Lung - therapy | Lung Neoplasms - immunology | Antigen Presentation | Aged, 80 and over | Adult | Female | Aged | Polymorphism, Single Nucleotide | Mutation | Cohort Studies | Histocompatibility antigens | Lung cancer, Non-small cell | Analysis | Immunotherapy | Tumor antigens | HLA histocompatibility antigens | Index Medicus
Journal Article
Nature (London), ISSN 0028-0836, 03/2019, Volume 567, Issue 7749, pp. 479 - 485
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Adenocarcinoma - pathology | Prognosis | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Lung Neoplasms - pathology | Male | Female | Adenocarcinoma - genetics | Gene Expression Regulation, Neoplastic - genetics | Tumor Escape - immunology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Antigens, Neoplasm - genetics | Antigens, Neoplasm - immunology | Carcinoma, Non-Small-Cell Lung - genetics | Adenocarcinoma - immunology | Antigen Presentation - immunology | Carcinoma, Squamous Cell - immunology | Carcinoma, Non-Small-Cell Lung - immunology | Tumor Microenvironment - immunology | Disease-Free Survival | Lung Neoplasms - immunology | Evolution, Molecular | Lymphocytes, Tumor-Infiltrating - immunology | Causes of | Development and progression | Genetic aspects | Cellular immunity | Lung cancer | RNA sequencing | Epigenetic inheritance | Medical colleges | Histocompatibility antigens | RNA | Tumor antigens | HLA histocompatibility antigens | Lung cancer, Non-small cell | Tumors | Working groups | Brain cancer | Editing | Genomes | Metastases | Gene sequencing | Histopathology | Lymphocytes | Evolution | Bioinformatics | Immune system | Antigens | T cell receptors | Ribonucleic acid--RNA | Estimates | Heterozygosity | White blood cells | Pathology | Depletion | Loss of heterozygosity | Epigenetics | Biomarkers | Ligands | Infiltration | Microenvironments | Mutation | Cancer | Index Medicus
Journal Article
Cancer cell, ISSN 1535-6108, 04/2018, Volume 33, Issue 4, pp. 649 - 663.e4
tremelimumab | IgG subclass | tumor immunotherapy | ipilimumab | antibody-dependent cell-mediated cytotoxicity | immune regulatory antibodies | CTLA-4 | Fc-gamma receptors | regulatory TÂ cell depletion | immune checkpoints | regulatory T cell depletion | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Antineoplastic Agents, Immunological - administration & dosage | Antibodies, Monoclonal - pharmacology | Humans | Treatment Outcome | Ipilimumab - pharmacology | Receptors, IgG - metabolism | Antineoplastic Agents, Immunological - pharmacology | T-Lymphocytes, Regulatory - immunology | Xenograft Model Antitumor Assays | Antibodies, Monoclonal, Humanized | Receptors, IgG - genetics | Animals | Antibodies, Monoclonal - administration & dosage | Melanoma - genetics | Melanoma - immunology | Melanoma - drug therapy | Cell Line, Tumor | Female | Mice | Polymorphism, Single Nucleotide | CTLA-4 Antigen - antagonists & inhibitors | Ipilimumab - administration & dosage | Viral antibodies | Fc receptors | Analysis | Immunotherapy | Melanoma | Antibodies | T cells | Index Medicus
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 12/2015, Volume 192, Issue 11, pp. 1298 - 1305
Clinical outcome | Antibiotic | Intensive care | Pharmacodynamics | Pharmacokinetics | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Prospective Studies | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Male | Treatment Outcome | Anti-Bacterial Agents - therapeutic use | Sepsis - drug therapy | Survival Analysis | Female | Aged | Infusions, Intravenous | beta-Lactams - therapeutic use | Anti-Bacterial Agents - administration & dosage | Length of Stay - statistics & numerical data | beta-Lactams - administration & dosage | Index Medicus | Abridged Index Medicus
Journal Article